CHRISTOPHER MORGAN: Open Payments
NPI 1891341335 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 19 payments from 12 companies in 2025. Trend: 2023 $823 · 2024 $726 · 2025 $406
Food & beverage: $406
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation | 2 | $53 |
| Novo Nordisk Inc | 2 | $53 |
| Merck Sharp & Dohme LLC | 3 | $50 |
| HEARTFLOW, INC. | 1 | $44 |
| Actelion Pharmaceuticals US, Inc. | 2 | $44 |
| PFIZER INC. | 2 | $34 |
| Boston Scientific Corporation | 1 | $32 |
| Alnylam Pharmaceuticals Inc. | 2 | $28 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: Tyvaso, Wegovy, VERQUVO, FFRct, UPTRAVI, VYNDAQEL, FARAPULSE, AMVUTTRA.
Industry payments across AL — which companies pay providers there.
